Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials

Objective: Accumulating evidence has been reported regarding the effect of dietary antioxidants on clinical variables in IBD patients, however, findings are controversial. This systematic review and meta-analysis aimed to investigate effect of dietary antioxidants on clinical variables in patients w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hossein Shahinfar, Nastaran Payandeh, Maryam ElhamKia, Fatemeh Abbasi, Alireza Alaghi, Farhang Djafari, Masoumeh Eslahi, Narjes Sadat Farizani Gohari, Parivash Ghorbaninejad, Mohaddeseh Hasanzadeh, Alireza Jafari, Aliyu Tijani Jibril, Reihane Khorasaniha, Elahe Mansouri, Vahid Monfared, Soroush Rezaee, Adel Salehian, Mahshid Shahavandi, Leila Sheikhi, Alireza Milajerdi
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/f7dd8b794a914141b0ebd0cd8556b2b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f7dd8b794a914141b0ebd0cd8556b2b0
record_format dspace
spelling oai:doaj.org-article:f7dd8b794a914141b0ebd0cd8556b2b02021-11-06T04:20:52ZAdministration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials0965-229910.1016/j.ctim.2021.102787https://doaj.org/article/f7dd8b794a914141b0ebd0cd8556b2b02021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S096522992100128Xhttps://doaj.org/toc/0965-2299Objective: Accumulating evidence has been reported regarding the effect of dietary antioxidants on clinical variables in IBD patients, however, findings are controversial. This systematic review and meta-analysis aimed to investigate effect of dietary antioxidants on clinical variables in patients with IBD or its subtypes. Methods: We searched PubMed, Scopus, and ISI Web of Science from inception to January 2021 using relevant keywords. Data were pooled by using the random-effect model. All statistical analyses were done using STATA version 14. Results: Our meta-analysis was exclusively done on studies about the effect of curcumin on IBD patients, because limited studies were done on other antioxidants. Curcumin administration resulted in significant increment of clinical remission in patients with IBD (SMD: 0.86%, 95% CI: 0.16, 1.56, p = 0.016), significant remission in clinical symptoms (SMD: −0.96 score, 95% CI: −1.34, −0.57, p < 0.001), and significant increment in endoscopic remission in IBD patients (SMD: 0.51%, 95% CI: 0.16, 0.85, p = 0.004), comparing to control group. Curcumin supplementation also made better clinical response than control group (SMD: 0.74%, 95% CI: 0.22, 1.26, p = 0.005) and also resulted in significant improvement in quality of life of patients with IBD, as compared to control group (SMD: 1.23 score, 95% CI: 0.72, 1.74, p < 0.001). Conclusions: Our meta-analysis showed that curcumin significantly improved clinical and endoscopic remissions in IBD patients. This supplementation also caused significant reduction in clinical symptoms of IBD patients along with better clinical response and the increased quality of life. Further researches with larger sample size and longer period of intervention are required to evaluate efficacy of dietary antioxidants on clinical variables in patients with IBD.Hossein ShahinfarNastaran PayandehMaryam ElhamKiaFatemeh AbbasiAlireza AlaghiFarhang DjafariMasoumeh EslahiNarjes Sadat Farizani GohariParivash GhorbaninejadMohaddeseh HasanzadehAlireza JafariAliyu Tijani JibrilReihane KhorasanihaElahe MansouriVahid MonfaredSoroush RezaeeAdel SalehianMahshid ShahavandiLeila SheikhiAlireza MilajerdiElsevierarticleAntioxidantsInflammatory bowel diseaseClinical remissionEndoscopic remissionMeta-analysisRandomized clinical trialOther systems of medicineRZ201-999ENComplementary Therapies in Medicine, Vol 63, Iss , Pp 102787- (2021)
institution DOAJ
collection DOAJ
language EN
topic Antioxidants
Inflammatory bowel disease
Clinical remission
Endoscopic remission
Meta-analysis
Randomized clinical trial
Other systems of medicine
RZ201-999
spellingShingle Antioxidants
Inflammatory bowel disease
Clinical remission
Endoscopic remission
Meta-analysis
Randomized clinical trial
Other systems of medicine
RZ201-999
Hossein Shahinfar
Nastaran Payandeh
Maryam ElhamKia
Fatemeh Abbasi
Alireza Alaghi
Farhang Djafari
Masoumeh Eslahi
Narjes Sadat Farizani Gohari
Parivash Ghorbaninejad
Mohaddeseh Hasanzadeh
Alireza Jafari
Aliyu Tijani Jibril
Reihane Khorasaniha
Elahe Mansouri
Vahid Monfared
Soroush Rezaee
Adel Salehian
Mahshid Shahavandi
Leila Sheikhi
Alireza Milajerdi
Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
description Objective: Accumulating evidence has been reported regarding the effect of dietary antioxidants on clinical variables in IBD patients, however, findings are controversial. This systematic review and meta-analysis aimed to investigate effect of dietary antioxidants on clinical variables in patients with IBD or its subtypes. Methods: We searched PubMed, Scopus, and ISI Web of Science from inception to January 2021 using relevant keywords. Data were pooled by using the random-effect model. All statistical analyses were done using STATA version 14. Results: Our meta-analysis was exclusively done on studies about the effect of curcumin on IBD patients, because limited studies were done on other antioxidants. Curcumin administration resulted in significant increment of clinical remission in patients with IBD (SMD: 0.86%, 95% CI: 0.16, 1.56, p = 0.016), significant remission in clinical symptoms (SMD: −0.96 score, 95% CI: −1.34, −0.57, p < 0.001), and significant increment in endoscopic remission in IBD patients (SMD: 0.51%, 95% CI: 0.16, 0.85, p = 0.004), comparing to control group. Curcumin supplementation also made better clinical response than control group (SMD: 0.74%, 95% CI: 0.22, 1.26, p = 0.005) and also resulted in significant improvement in quality of life of patients with IBD, as compared to control group (SMD: 1.23 score, 95% CI: 0.72, 1.74, p < 0.001). Conclusions: Our meta-analysis showed that curcumin significantly improved clinical and endoscopic remissions in IBD patients. This supplementation also caused significant reduction in clinical symptoms of IBD patients along with better clinical response and the increased quality of life. Further researches with larger sample size and longer period of intervention are required to evaluate efficacy of dietary antioxidants on clinical variables in patients with IBD.
format article
author Hossein Shahinfar
Nastaran Payandeh
Maryam ElhamKia
Fatemeh Abbasi
Alireza Alaghi
Farhang Djafari
Masoumeh Eslahi
Narjes Sadat Farizani Gohari
Parivash Ghorbaninejad
Mohaddeseh Hasanzadeh
Alireza Jafari
Aliyu Tijani Jibril
Reihane Khorasaniha
Elahe Mansouri
Vahid Monfared
Soroush Rezaee
Adel Salehian
Mahshid Shahavandi
Leila Sheikhi
Alireza Milajerdi
author_facet Hossein Shahinfar
Nastaran Payandeh
Maryam ElhamKia
Fatemeh Abbasi
Alireza Alaghi
Farhang Djafari
Masoumeh Eslahi
Narjes Sadat Farizani Gohari
Parivash Ghorbaninejad
Mohaddeseh Hasanzadeh
Alireza Jafari
Aliyu Tijani Jibril
Reihane Khorasaniha
Elahe Mansouri
Vahid Monfared
Soroush Rezaee
Adel Salehian
Mahshid Shahavandi
Leila Sheikhi
Alireza Milajerdi
author_sort Hossein Shahinfar
title Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
title_short Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
title_full Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
title_fullStr Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
title_full_unstemmed Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
title_sort administration of dietary antioxidants for patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled clinical trials
publisher Elsevier
publishDate 2021
url https://doaj.org/article/f7dd8b794a914141b0ebd0cd8556b2b0
work_keys_str_mv AT hosseinshahinfar administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT nastaranpayandeh administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT maryamelhamkia administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT fatemehabbasi administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT alirezaalaghi administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT farhangdjafari administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT masoumeheslahi administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT narjessadatfarizanigohari administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT parivashghorbaninejad administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT mohaddesehhasanzadeh administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT alirezajafari administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT aliyutijanijibril administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT reihanekhorasaniha administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT elahemansouri administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT vahidmonfared administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT soroushrezaee administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT adelsalehian administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT mahshidshahavandi administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT leilasheikhi administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
AT alirezamilajerdi administrationofdietaryantioxidantsforpatientswithinflammatoryboweldiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledclinicaltrials
_version_ 1718443955596558336